Sepracor regulatory update

SEPR received U.S. patent No. 5,474,997 covering compositions containing 2R,4S - itraconazole, and a method for treating local and systemic fungal and yeast infections, while avoiding the accompanying problems of adverse effects associated with the conventional form of the drug. ...